- Disease: Acute SARS-CoV-2
- Study type: Observational Cohort Study
- Study type descriptors: Prospective, Single centre
- Study aim: To investigate the potential prognostic role of neutrophil and lymphocyte count regarding tocilizumab treatment in patients with severe COVID-19 pneumonia and high concentration of IL-6
- Number of participants enrolled: 31
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- Adults
- Elderly
- Hospital wide
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Monoclonal antibodies
- Tocilizumab
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to